FYR DIAGNOSTICS, INC.
Non-invasive diagnostic assay from umbilical cord samples using miRNA signatures to detect severe neonatal opioid withdrawal syndrome (NOWS)
- Sector
- Medtech
- Headquarters
- MISSOULA, MT
- Founded
- 2020
- Latest Form D
- $8M, Aug 2024
- Total capital
- $10.2M
- Federal grants
- $2.2M
- 6 awards · 2019–2021
- Rank in peer group#59 of 79
- Private capital raised
- $8M
- 1 Form D · last Aug 2024
- 26 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 2 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 1st filing$8M
- Federal grantHealth and Human S · Phase I · PCR-based miRNA assessment of neonatal opioid withdrawal syndrome (NOWS) severity$351K
- Federal grantHealth and Human S · Phase II · PCR-based miRNA assessment of neonatal opioid withdrawal syndrome (NOWS) severity$351K
- Federal grantNSF · Phase I · SBIR Phase I: The early detection of HLB Disease in citrus trees utilizing a novel isothermal PCR technology to identify host small RNAs$256K
- Federal grantHealth and Human S · Phase I · Project isoPTE: isothermic post-traumatic epilepsy miRNA biomarker detection$284K
- Federal grantHealth and Human S · Phase I · Project isoPTE: isothermic post-traumatic epilepsy miRNA biomarker detection$618K
- Federal grantHealth and Human S · Phase I · Project isoPTE: isothermic post-traumatic epilepsy miRNA biomarker detection$334K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Federal first
60months
from FYR DIAGNOSTICS, INC.’s first federal award to its first private round.
- First federal award · Aug 2019
- Health and Human S · $334K
- First Form D · Aug 2024
- $8M · 1st Form D
- Awards before first raise
- 6 awards
An association in public records, not a cause or a prediction.
Standing among 79 peers
Line = medianMedtech · Instrument
- Federal grantsBelow median
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
Researcher links verified by same-company patents and grants- Sarjubhai PatelResearcherExecutive Officer, DirectorLinked by $1.2M in grants as PI
- Avery SonnenbergDirectorNamed in SEC Form D filings
- Brian ConwayExecutive OfficerNamed in SEC Form D filings
- Christopher BoothExecutive Officer, DirectorNamed in SEC Form D filings
- Michael GoguenDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 2- PendingCompositions And Methods For Detection Of Gene ExpressionUSPTOApplication PCTUS2025043347
- PendingCompositions And Methods For Detection Of Gene ExpressionUSPTOApplication 63686914
Related companies, and why
- FYR Diagnostics, LLCShares a founder: SARJUBHAI PATEL
- ZENFLOW, INC.Similar federal contract value in Medtech · null in contracts
- SIMPLYBREATHE L.L.C.Similar federal contract value in Medtech · null in contracts
- Biocogniv Inc.Similar federal contract value in Medtech · null in contracts
- Mobile Sleep Technologies L.L.CSimilar federal contract value in Medtech · null in contracts
- CONCENTRIS SYSTEMS LLCSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .